2014 Emerging Science Series - April 23, 2014

Updated:Apr 23,2014

The 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: Implications for Intervention and the Impact of Transcatheter Interventions

Login or Register for Free Webinar BUTTON 247x28

AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease
Wednesday, April 23, 2014, Noon CDT


Robert O. Bonow, MD, MACC, FAHA
Northwestern University Feinberg School of Medicine
Chicago, IL
Past AHA President and Chair of the Emerging Science Series Committee
Guideline Writing Group Member

Timothy J. Gardner, MD, FAHA
Medical Director, Center for Heart & Vascular Health
Executive Director, Value Institute
Christiana Hospital
Newark, DE
Past AHA President

Catherine M. Otto, MD, FACC, FAHA
J. Ward Kennedy-Hamilton Endowed Chair in Cardiology, Professor of Medicine and Director of the Heart Valve Clinic at the University Of Washington School Of Medicine
Seattle, WA 
Guideline Writing Group Co-Chair

Blase A Carabello, MD, FACC
Professor of Medicine, Icahn School of Medicine
Chairman, Mount Sinai Beth Israel Department of Cardiology
New York, NY
Guideline Writing Group Member

Michael Mack, MD
Medical Director, Cardiovascular Services
Baylor Scott & White Health
Former Chair of the Transcatheter Valve Therapy Registry of the American College of Cardiology and Past President of the Society of Thoracic Surgeons

No CME/CE credit for this activity is provided.